Empirical Study on Lifestyle Intervention for Elderly Hypertensive Patients in Community Based on TTM Theory

March 18, 2026 updated by: Qu Shen
This study intervention is based on TTM theory and implements lifestyle interventions, including nutritious diet, regular exercise, social support, sleep optimization, avoidance of addictive substances, and stress management. Through various means such as training, guidance, and motivation, motivation is formed, goals are determined, and habits are strengthened, ultimately leading to the development of a healthy lifestyle, control of blood pressure indicators, and improvement of quality of life and cognitive function. The intervention period is a total of 3 weeks, on line.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

106

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Patients whose blood pressure measurements taken at community hospitals meet the hypertension criteria outlined in the Chinese Guidelines for the Prevention and Treatment of Hypertension (2024 revision);
  2. Aged 60-75 years old;
  3. Have certain abilities in reading, comprehension, and communication;
  4. Able to use a smartphone;
  5. In the pre-conscious/conscious/preparatory stage.
  6. Volunteer to participate in this study and sign the informed consent form.

Exclusion Criteria:

  1. Exclude those with a history of severe heart, brain, kidney diseases or cancer;
  2. Patients who currently have or have previously had mental disorders;
  3. Patients who are currently participating in other research projects.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Lifestyle medicine
Behavioral: Lifestyle medicine
Lifestyle medicine includes Nutrition , Physical Activity , Stress Management, Restorative Sleep , Social Connectedness, Avoidance of Risky Substances .
No Intervention: Routine health education

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
blood pressure
Time Frame: Baseline, the end of treatment at 3 weeks, and after 3 months
Baseline, the end of treatment at 3 weeks, and after 3 months
Patient quality of life (SF-36)
Time Frame: Baseline, the end of treatment at 3 weeks, and after 3 months
Baseline, the end of treatment at 3 weeks, and after 3 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Patient cognitive function (AD8)
Time Frame: Baseline, the end of treatment at 3 weeks, and after 3 months
Baseline, the end of treatment at 3 weeks, and after 3 months
Patients' lifestyle (HPLP Ⅱ)
Time Frame: Baseline, the end of treatment at 3 weeks, and after 3 months
Baseline, the end of treatment at 3 weeks, and after 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Qu Shen

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2026

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

December 30, 2026

Study Registration Dates

First Submitted

December 4, 2025

First Submitted That Met QC Criteria

March 18, 2026

First Posted (Actual)

March 25, 2026

Study Record Updates

Last Update Posted (Actual)

March 25, 2026

Last Update Submitted That Met QC Criteria

March 18, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • XDYX202509K38

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe